Financials
- Market Capitalization 76.28 M
- Employee 76
- Founded 2018
- CEO N/A
- Website www.acrivon.com
- Headquarter Massachusetts, United States
- FIGI BBG011RWR2Q4
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.19
Fiyat/satışlar oranı
464.04
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3971 | NMRA Neumora Therapeutics, Inc. - Common Stock | 0.41 USD | -6.82% | -18.00% | -60.19% | -77.84% | 77.04 M USD | ||
| 3973 | OKYO OKYO Pharma Limited - American Depositary Shares | 1.46 USD | +1.39% | -2.01% | +5.80% | -25.13% | 76.62 M USD | ||
| 3981 | TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.10 USD | 0.00% | -18.52% | -1.79% | -37.14% | 75.65 M USD | ||
| 3984 | VRCA Verrica Pharmaceuticals Inc. - Common Stock | 3.81 USD | -4.99% | -10.77% | -22.40% | -36.71% | 65.45 M USD |